Madan Jagasia, M.B.B.S.

Professor

madan.jagasia@vanderbilt.edu
Faculty Appointments
Professor of Medicine
Education
M.S.C.I., Clinical Investigation , Vanderbilt University, Nashville, TennesseeM.B.B.S., Medicine, King Edward Memorial Hospital-College, Mumbai, IndiaB.S., Ramnarain Ruia College, Mumbai, India
Office Address
2665 TVC
1301 22nd Avenue, South
Nashville, TN 37232-5505
Research Description
Clinical trials in GVHD, new drugs in leukemia, lymphoma and myeloma. Novel preparative regimen for stem cell transplant.
Research Keywords
Stem cell transplant, leukemia, lymphoma, myeloma
Clinical Research Keywords
Hematologic malignancies,stem cell transplantation, leukemia, lymphoma
Publications
Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA, Arora M, Cutler C, Jagasia M, Pidala J, Hamilton BK, Chen GL, Pusic I, Lee SJ, Paczesny S. Biomarker Panel for Chronic Graft-Versus-Host Disease. J. Clin. Oncol [print-electronic]. 2016 May 5/23/2016; PMID: 27217465, PII: JCO.2015.65.9615, DOI: 10.1200/JCO.2015.65.9615, ISSN: 1527-7755.

Engelhardt BG, Paczesny S, Jung DK, Daguindau E, Jagasia M, Savani BN, Chinratanalab W, Cornell RF, Goodman S, Greer JP, Kassim AA, Sengsayadeth S, Yoder SM, Rock MT, Crowe JE. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation [letter]. Haematologica [print-electronic]. 2016 May; 101(5): e204-8. PMID: 26819055, PII: haematol.2015.139501, DOI: 10.3324/haematol.2015.139501, ISSN: 1592-8721.

Arora M, Cutler CS, Jagasia MH, Pidala J, Chai X, Martin PJ, Flowers ME, Inamoto Y, Chen GL, Wood WA, Khera N, Palmer J, Duong H, Arai S, Mayer S, Pusic I, Lee SJ. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 449-55. PMID: 26541363, PMCID: PMC4787270, PII: S1083-8791(15)00707-7, DOI: 10.1016/j.bbmt.2015.10.018, ISSN: 1523-6536.

Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, Wang L, Fonnesbeck C, Jagasia M. Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients. Biol. Blood Marrow Transplant [print-electronic]. 2016 Mar; 22(3): 528-35. PMID: 26705931, PII: S1083-8791(15)01864-9, DOI: 10.1016/j.bbmt.2015.12.003, ISSN: 1523-6536.

Li W, Cornell RF, Lenihan D, Slosky D, Jagasia M, Piazza G, Moslehi J. Cardiovascular Complications of Novel Multiple Myeloma Treatments. Circulation. 2016 Mar 3/1/2016; 133(9): 908-12. PMID: 26927008, PII: CIRCULATIONAHA.115.018351, DOI: 10.1161/CIRCULATIONAHA.115.018351, ISSN: 1524-4539.

Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia MH, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM, Martin PJ, Sarantopoulos S, Lee SJ, Flowers ME. A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation. Clin. Cancer Res [print-electronic]. 2016 Jan 1/15/2016; 22(2): 319-27. PMID: 26378033, PMCID: PMC4715914, PII: 1078-0432.CCR-15-1443, DOI: 10.1158/1078-0432.CCR-15-1443, ISSN: 1078-0432.

Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, Ordemann R, Qayed M, Renteria AS, Reshef R, Wölfl M, Chen YB, Goldstein S, Jagasia M, Locatelli F, Mielke S, Porter D, Schechter T, Shekhovtsova Z, Ferrara JL, Levine JE. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium. Biol. Blood Marrow Transplant [print-electronic]. 2016 Jan; 22(1): 4-10. PMID: 26386318, PMCID: PMC4706482, PII: S1083-8791(15)00602-3, DOI: 10.1016/j.bbmt.2015.09.001, ISSN: 1523-6536.

Rioth MJ, Warner J, Savani BN, Jagasia M. Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology. Bone Marrow Transplant [print-electronic]. 2016 Jan; 51(1): 34-40. PMID: 26367235, PII: bmt2015210, DOI: 10.1038/bmt.2015.210, ISSN: 1476-5365.

Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A. Sexual health in hematopoietic stem cell transplant recipients. Cancer [print-electronic]. 2015 Dec 12/1/2015; 121(23): 4124-31. PMID: 26372459, DOI: 10.1002/cncr.29675, ISSN: 1097-0142.

Booth GS, Gehrie EA, Jagasia MH, Shaw BE, Savani BN. When Can You Discard Stem Cells? [letter]. Biol. Blood Marrow Transplant [print-electronic]. 2015 Nov; 21(11): 2033. PMID: 26253004, PII: S1083-8791(15)00501-7, DOI: 10.1016/j.bbmt.2015.07.024, ISSN: 1523-6536.

Krupski C, Jagasia M. Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead. Curr Hematol Malig Rep. 2015 Sep; 10(3): 183-91. PMID: 26303672, DOI: 10.1007/s11899-015-0265-2, ISSN: 1558-822X.

Sun YC, Chai X, Inamoto Y, Pidala J, Martin PJ, Flowers ME, Shen TT, Lee SJ, Jagasia M. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life. Biol. Blood Marrow Transplant [print-electronic]. 2015 Sep; 21(9): 1687-91. PMID: 26033283, PMCID: PMC4537831, PII: S1083-8791(15)00377-8, DOI: 10.1016/j.bbmt.2015.05.020, ISSN: 1523-6536.

Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, Pidala J, Olivieri A, Martin PJ, Przepiorka D, Pusic I, Dignan F, Mitchell SA, Lawitschka A, Jacobsohn D, Hall AM, Flowers ME, Schultz KR, Vogelsang G, Pavletic S. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol. Blood Marrow Transplant [print-electronic]. 2015 Jun; 21(6): 984-99. PMID: 25796139, PII: S1083-8791(15)00155-X, DOI: 10.1016/j.bbmt.2015.02.025, ISSN: 1523-6536.

Palmer J, Chai X, Martin PJ, Weisdorf D, Inamoto Y, Pidala J, Jagasia M, Pavletic S, Cutler C, Vogelsang G, Arai S, Flowers ME, Lee SJ. Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease. Haematologica [print-electronic]. 2015 May; 100(5): 690-5. PMID: 25715403, PMCID: PMC4420219, PII: haematol.2014.117283, DOI: 10.3324/haematol.2014.117283, ISSN: 1592-8721.

Paczesny S, Hakim FT, Pidala J, Cooke KR, Lathrop J, Griffith LM, Hansen J, Jagasia M, Miklos D, Pavletic S, Parkman R, Russek-Cohen E, Flowers ME, Lee S, Martin P, Vogelsang G, Walton M, Schultz KR. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report. Biol. Blood Marrow Transplant [print-electronic]. 2015 May; 21(5): 780-92. PMID: 25644957, PMCID: PMC4408233, PII: S1083-8791(15)00007-5, DOI: 10.1016/j.bbmt.2015.01.003, ISSN: 1523-6536.

Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. Clin. Cancer Res [print-electronic]. 2015 May 5/1/2015; 21(9): 2020-8. PMID: 25348512, PMCID: PMC4411210, PII: 1078-0432.CCR-14-0586, DOI: 10.1158/1078-0432.CCR-14-0586, ISSN: 1078-0432.

Boyiadzis M, Arora M, Klein JP, Hassebroek A, Hemmer M, Urbano-Ispizua A, Antin JH, Bolwell BJ, Cahn JY, Cairo MS, Cutler CS, Flowers ME, Gale RP, Herzig R, Isola LM, Jacobsohn DA, Jagasia MH, Klumpp TR, Lee SJ, Petersdorf EW, Santarone S, Spellman SR, Schouten HC, Verdonck LF, Wingard JR, Weisdorf DJ, Horowitz MM, Pavletic SZ. Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia. Clin. Cancer Res [print-electronic]. 2015 May 5/1/2015; 21(9): 2020-8. PMID: 25348512, PMCID: PMC4411210, PII: 1078-0432.CCR-14-0586, DOI: 10.1158/1078-0432.CCR-14-0586, ISSN: 1078-0432.

Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol. Blood Marrow Transplant [print-electronic]. 2015 Apr; 21(4): 589-603. PMID: 25639770, PMCID: PMC4359636, PII: S1083-8791(14)01475-X, DOI: 10.1016/j.bbmt.2014.12.031, ISSN: 1523-6536.

Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME. Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. Biol. Blood Marrow Transplant [print-electronic]. 2015 Apr; 21(4): 640-5. PMID: 25528390, PMCID: PMC4359642, PII: S1083-8791(14)00661-2, DOI: 10.1016/j.bbmt.2014.10.022, ISSN: 1523-6536.

Arora M, Hemmer MT, Ahn KW, Klein JP, Cutler CS, Urbano-Ispizua A, Couriel DR, Alousi AM, Gale RP, Inamoto Y, Weisdorf DJ, Li P, Antin JH, Bolwell BJ, Boyiadzis M, Cahn JY, Cairo MS, Isola LM, Jacobsohn DA, Jagasia M, Klumpp TR, Petersdorf EW, Santarone S, Schouten HC, Wingard JR, Spellman SR, Pavletic SZ, Lee SJ, Horowitz MM, Flowers ME. Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort. Biol. Blood Marrow Transplant [print-electronic]. 2015 Apr; 21(4): 640-5. PMID: 25528390, PMCID: PMC4359642, PII: S1083-8791(14)00661-2, DOI: 10.1016/j.bbmt.2014.10.022, ISSN: 1523-6536.

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol. Blood Marrow Transplant [print-electronic]. 2015 Mar; 21(3): 389-401.e1. PMID: 25529383, PMCID: PMC4329079, PII: S1083-8791(14)01378-0, DOI: 10.1016/j.bbmt.2014.12.001, ISSN: 1523-6536.

Guo Y, Bosompem A, Mohan S, Erdogan B, Ye F, Vickers KC, Sheng Q, Zhao S, Li CI, Su PF, Jagasia M, Strickland SA, Griffiths EA, Kim AS. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics. 2015; 16: 727. PMID: 26400237, PMCID: PMC4581457, PII: 10.1186/s12864-015-1929-y, DOI: 10.1186/s12864-015-1929-y, ISSN: 1471-2164.

Majhail NS, Jagasia M. Referral to transplant center for hematopoietic cell transplantation. Hematol. Oncol. Clin. North Am [print-electronic]. 2014 Dec; 28(6): 1201-13. PMID: 25459188, PII: S0889-8588(14)00107-5, DOI: 10.1016/j.hoc.2014.08.007, ISSN: 1558-1977.

Majhail NS, Jagasia M. Referral to transplant center for hematopoietic cell transplantation. Hematol. Oncol. Clin. North Am [print-electronic]. 2014 Dec; 28(6): 1201-13. PMID: 25459188, PII: S0889-8588(14)00107-5, DOI: 10.1016/j.hoc.2014.08.007, ISSN: 1558-1977.

Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica [print-electronic]. 2014 Nov; 99(11): 1746-52. PMID: 25150260, PMCID: PMC4222474, PII: haematol.2014.108217, DOI: 10.3324/haematol.2014.108217, ISSN: 1592-8721.

Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M. Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica [print-electronic]. 2014 Nov; 99(11): 1746-52. PMID: 25150260, PMCID: PMC4222474, PII: haematol.2014.108217, DOI: 10.3324/haematol.2014.108217, ISSN: 1592-8721.

Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf DJ, Pidala J, Flowers ME, Arora M, Jagasia M, Arai S, Chai X, Pavletic SZ, Vogelsang GB, Lee SJ, . Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease. Haematologica [print-electronic]. 2014 Oct; 99(10): 1618-23. PMID: 24997150, PMCID: PMC4181259, PII: haematol.2014.109611, DOI: 10.3324/haematol.2014.109611, ISSN: 1592-8721.

Pauff JM, Gonzalez RS, Sajnani KP, Kassim A, Jagasia M. Post-allograft pomalidomide and reversible hepatotoxicity [letter]. Bone Marrow Transplant [print-electronic]. 2014 Oct; 49(10): 1341-2. PMID: 24955783, PII: bmt2014128, DOI: 10.1038/bmt.2014.128, ISSN: 1476-5365.

Pauff JM, Gonzalez RS, Sajnani KP, Kassim A, Jagasia M. Post-allograft pomalidomide and reversible hepatotoxicity [letter]. Bone Marrow Transplant [print-electronic]. 2014 Oct; 49(10): 1341-2. PMID: 24955783, PII: bmt2014128, DOI: 10.1038/bmt.2014.128, ISSN: 1476-5365.

Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf DJ, Pidala J, Flowers ME, Arora M, Jagasia M, Arai S, Chai X, Pavletic SZ, Vogelsang GB, Lee SJ, . Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease. Haematologica [print-electronic]. 2014 Oct; 99(10): 1618-23. PMID: 24997150, PMCID: PMC4181259, PII: haematol.2014.109611, DOI: 10.3324/haematol.2014.109611, ISSN: 1592-8721.

Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin. Haematologica [print-electronic]. 2014 Sep; 99(9): e148-51. PMID: 24951465, PMCID: PMC4562545, PII: haematol.2014.105452, DOI: 10.3324/haematol.2014.105452, ISSN: 1592-8721.

El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J, Flowers M, Weisdorf D, Pavletic S, Jaglowski S, Jagasia M, Lee SJ, Chen YB. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol. Blood Marrow Transplant [print-electronic]. 2014 Sep; 20(9): 1341-8. PMID: 24813171, PMCID: PMC4127362, PII: S1083-8791(14)00285-7, DOI: 10.1016/j.bbmt.2014.05.001, ISSN: 1523-6536.

El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J, Flowers M, Weisdorf D, Pavletic S, Jaglowski S, Jagasia M, Lee SJ, Chen YB. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol. Blood Marrow Transplant [print-electronic]. 2014 Sep; 20(9): 1341-8. PMID: 24813171, PMCID: PMC4127362, PII: S1083-8791(14)00285-7, DOI: 10.1016/j.bbmt.2014.05.001, ISSN: 1523-6536.

Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin. Haematologica [print-electronic]. 2014 Sep; 99(9): e148-51. PMID: 24951465, PMCID: PMC4562545, PII: haematol.2014.105452, DOI: 10.3324/haematol.2014.105452, ISSN: 1592-8721.

Frangoul H, Jagasia M. Relapse post hematopoietic SCT remains the Achilles heel for the field [editorial]. Bone Marrow Transplant. 2014 Aug; 49(8): 997-8. PMID: 25096916, PII: bmt2014134, DOI: 10.1038/bmt.2014.134, ISSN: 1476-5365.

Frangoul H, Jagasia M. Relapse post hematopoietic SCT remains the Achilles heel for the field [editorial]. Bone Marrow Transplant. 2014 Aug; 49(8): 997-8. PMID: 25096916, PII: bmt2014134, DOI: 10.1038/bmt.2014.134, ISSN: 1476-5365.

McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ. Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 960-8. PMID: 24641829, PMCID: PMC4057955, PII: S1083-8791(14)00162-1, DOI: 10.1016/j.bbmt.2014.03.013, ISSN: 1523-6536.

McClune BL, Ahn KW, Wang HL, Antin JH, Artz AS, Cahn JY, Deol A, Freytes CO, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Aljurf MD, Akpek G, Bacher U, Chao NJ, Chen YB, Cooper BW, Dehn J, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ. Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jul; 20(7): 960-8. PMID: 24641829, PMCID: PMC4057955, PII: S1083-8791(14)00162-1, DOI: 10.1016/j.bbmt.2014.03.013, ISSN: 1523-6536.

Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jun; 20(6): 900-3. PMID: 24631737, PMCID: PMC4034271, PII: S1083-8791(14)00154-2, DOI: 10.1016/j.bbmt.2014.03.005, ISSN: 1523-6536.

Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jun; 20(6): 900-3. PMID: 24631737, PMCID: PMC4034271, PII: S1083-8791(14)00154-2, DOI: 10.1016/j.bbmt.2014.03.005, ISSN: 1523-6536.

Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI, Strickland SA, Jagasia M, Savani BN, Fraser JW, Sadrzadeh H, Rajkhowa T, Ito S, Jain NA, Battiwalla M, Fathi AT, Levis MJ, Barrett AJ, Hourigan CS. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues [letter]. Leukemia [print-electronic]. 2014 May; 28(5): 1167-70. PMID: 24472813, PMCID: PMC4013200, PII: leu201414, DOI: 10.1038/leu.2014.14, ISSN: 1476-5551.

Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI, Strickland SA, Jagasia M, Savani BN, Fraser JW, Sadrzadeh H, Rajkhowa T, Ito S, Jain NA, Battiwalla M, Fathi AT, Levis MJ, Barrett AJ, Hourigan CS. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues [letter]. Leukemia [print-electronic]. 2014 May; 28(5): 1167-70. PMID: 24472813, PMCID: PMC4013200, PII: leu201414, DOI: 10.1038/leu.2014.14, ISSN: 1476-5551.

Inamoto Y, Jagasia M, Wood WA, Pidala J, Palmer J, Khera N, Weisdorf D, Carpenter PA, Flowers ME, Jacobsohn D, Martin PJ, Lee SJ, Pavletic SZ, . Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transplant [print-electronic]. 2014 Apr; 49(4): 532-8. PMID: 24464142, PMCID: PMC3975688, PII: bmt2013225, DOI: 10.1038/bmt.2013.225, ISSN: 1476-5365.

Inamoto Y, Jagasia M, Wood WA, Pidala J, Palmer J, Khera N, Weisdorf D, Carpenter PA, Flowers ME, Jacobsohn D, Martin PJ, Lee SJ, Pavletic SZ, . Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transplant [print-electronic]. 2014 Apr; 49(4): 532-8. PMID: 24464142, PMCID: PMC3975688, PII: bmt2013225, DOI: 10.1038/bmt.2013.225, ISSN: 1476-5365.

Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, Arora M, Jagasia M, Vogelsang GB, Lee SJ. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol. Blood Marrow Transplant [print-electronic]. 2014 Mar; 20(3): 337-44. PMID: 24315845, PMCID: PMC3973401, PII: S1083-8791(13)00562-4, DOI: 10.1016/j.bbmt.2013.11.025, ISSN: 1523-6536.

Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, Arora M, Jagasia M, Vogelsang GB, Lee SJ. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol. Blood Marrow Transplant [print-electronic]. 2014 Mar; 20(3): 337-44. PMID: 24315845, PMCID: PMC3973401, PII: S1083-8791(13)00562-4, DOI: 10.1016/j.bbmt.2013.11.025, ISSN: 1523-6536.

Sengsayadeth S, Savani BN, Jagasia M, Goodman S, Greer JP, Chen H, Chinratanalab W, Kassim AA, Engelhardt BG. Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials. Bone Marrow Transplant [print-electronic]. 2014 Feb; 49(2): 236-40. PMID: 24096824, PMCID: PMC3946331, PII: bmt2013157, DOI: 10.1038/bmt.2013.157, ISSN: 1476-5365.

Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 89-97. PMID: 24161923, PMCID: PMC3886623, PII: S1083-8791(13)00495-3, DOI: 10.1016/j.bbmt.2013.10.018, ISSN: 1523-6536.

Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 89-97. PMID: 24161923, PMCID: PMC3886623, PII: S1083-8791(13)00495-3, DOI: 10.1016/j.bbmt.2013.10.018, ISSN: 1523-6536.

Ragon BK, Clifton C, Chen H, Savani BN, Engelhardt BG, Kassim AA, Vaughan LA, Lucid C, Jagasia M. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol. Blood Marrow Transplant [print-electronic]. 2014 Jan; 20(1): 53-7. PMID: 24120525, PII: S1083-8791(13)00450-3, DOI: 10.1016/j.bbmt.2013.10.004, ISSN: 1523-6536.

Reddy NM, Oluwole O, Greer JP, Engelhardt BG, Jagasia MH, Savani BN. Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma. Exp. Hematol [print-electronic]. 2014 Jan; 42(1): 39-45. PMID: 24096123, PII: S0301-472X(13)00747-9, DOI: 10.1016/j.exphem.2013.09.012, ISSN: 1873-2399.

Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am. J. Clin. Pathol. 2013 Nov; 140(5): 643-50. PMID: 24124142, PMCID: PMC4159763, PII: 140/5/643, DOI: 10.1309/AJCP8CKE9NEINQFL, ISSN: 1943-7722.

Vaughan LA, Vu M, Sengsayadeth S, Lucid C, Clifton C, McCarty K, Hagaman D, Domm J, Kassim A, Chinratanalab W, Goodman S, Greer J, Frangoul H, Engelhardt BG, Jagasia M, Savani BN. New allergies after cord blood transplantation. Cytotherapy. 2013 Oct; 15(10): 1259-65. PMID: 23993300, PII: S1465-3249(13)00550-1, DOI: 10.1016/j.jcyt.2013.05.018, ISSN: 1477-2566.

Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Socie G. Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Biol. Blood Marrow Transplant [print-electronic]. 2013 Jul; 19(7): 1129-33. PMID: 23623892, PII: S1083-8791(13)00186-9, DOI: 10.1016/j.bbmt.2013.04.018, ISSN: 1523-6536.

Wulff-Burchfield EM, Jagasia M, Savani BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant [print-electronic]. 2013 Apr; 48(4): 469-73. PMID: 22732697, PII: bmt2012123, DOI: 10.1038/bmt.2012.123, ISSN: 1476-5365.

Reddy N, Oluwole O, Greer JP, Goodman S, Engelhardt B, Jagasia MH, Savani BN. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk [print-electronic]. 2012 Dec; 12(6): 406-11. PMID: 22981964, PII: S2152-2650(12)00136-X, DOI: 10.1016/j.clml.2012.07.003, ISSN: 2152-2669.

Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Exp. Hematol [print-electronic]. 2012 Dec; 40(12): 974-982.e1. PMID: 22885125, PMCID: PMC3611587, PII: S0301-472X(12)00343-8, DOI: 10.1016/j.exphem.2012.08.002, ISSN: 1873-2399.

Sengsayadeth SM, Jagasia M, Engelhardt BG, Kassim A, Strickland SA, Goodman S, Lucid C, Vnencak-Jones CL, Greer JP, Savani BN. Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplant [print-electronic]. 2012 Dec; 47(12): 1535-7. PMID: 22659680, PII: bmt201288, DOI: 10.1038/bmt.2012.88, ISSN: 1476-5365.

Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet?. Biol. Blood Marrow Transplant [print-electronic]. 2012 Dec; 18(12): 1790-9. PMID: 22626785, PII: S1083-8791(12)00211-X, DOI: 10.1016/j.bbmt.2012.05.009, ISSN: 1523-6536.

Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant [print-electronic]. 2012 Nov; 47(11): 1470-3. PMID: 22484321, PII: bmt201256, DOI: 10.1038/bmt.2012.56, ISSN: 1476-5365.

Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2012 Oct; 18(10): 1479-87. PMID: 22449611, PII: S1083-8791(12)00120-6, DOI: 10.1016/j.bbmt.2012.03.008, ISSN: 1523-6536.

Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH, Savani BN. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant [print-electronic]. 2012 Oct; 47(10): 1318-20. PMID: 22327132, PII: bmt201210, DOI: 10.1038/bmt.2012.10, ISSN: 1476-5365.

Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant [print-electronic]. 2012 Oct; 47(10): 1350-5. PMID: 22327131, PII: bmt2011261, DOI: 10.1038/bmt.2011.261, ISSN: 1476-5365.

Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol. Blood Marrow Transplant [print-electronic]. 2012 Jul; 18(7): 1069-75. PMID: 22178694, PII: S1083-8791(11)01080-9, DOI: 10.1016/j.bbmt.2011.12.518, ISSN: 1523-6536.

Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Exp. Hematol [print-electronic]. 2012 Jun; 40(6): 431-5. PMID: 22269114, PMCID: PMC4067702, PII: S0301-472X(12)00016-1, DOI: 10.1016/j.exphem.2012.01.014, ISSN: 1873-2399.

Reddy N, Greer JP, Goodman S, Kassim A, Morgan DS, Chinratanalab W, Brandt S, Englehardt B, Oluwole O, Jagasia MH, Savani BN. Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen. Exp. Hematol [print-electronic]. 2012 May; 40(5): 359-66. PMID: 22269117, PII: S0301-472X(12)00014-8, DOI: 10.1016/j.exphem.2012.01.012, ISSN: 1873-2399.

Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood [print-electronic]. 2012 Mar 3/8/2012; 119(10): 2417-21. PMID: 22262764, PMCID: PMC3311262, PII: blood-2011-10-384750, DOI: 10.1182/blood-2011-10-384750, ISSN: 1528-0020.

Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood [print-electronic]. 2012 Jan 1/5/2012; 119(1): 296-307. PMID: 22010102, PMCID: PMC3251233, PII: blood-2011-06-364265, DOI: 10.1182/blood-2011-06-364265, ISSN: 1528-0020.

Gunasekaran U, Agarwal N, Jagasia MH, Jagasia SM. Endocrine complications in long-term survivors after allogeneic stem cell transplant. Semin. Hematol. 2012 Jan; 49(1): 66-72. PMID: 22221786, PII: S0037-1963(11)00104-1, DOI: 10.1053/j.seminhematol.2011.10.010, ISSN: 1532-8686.

Jagasia MH, Savani BN, Neff A, Dixon S, Chen H, Pickard AS. Outcome, toxicity profile and cost analysis of autologous stem cell mobilization. Bone Marrow Transplant [print-electronic]. 2011 Aug; 46(8): 1084-8. PMID: 21042307, PII: bmt2010254, DOI: 10.1038/bmt.2010.254, ISSN: 1476-5365.

Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD. Blood [print-electronic]. 2011 Jul 7/28/2011; 118(4): 1140-4. PMID: 21628416, PII: blood-2010-09-310011, DOI: 10.1182/blood-2010-09-310011, ISSN: 1528-0020.

McClintock-Treep SA, Briggs RC, Shults KE, Flye-Blakemore LA, Mosse CA, Jagasia MH, Shinar AA, Dupont WD, Stelzer GT, Head DR. Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow. Am. J. Clin. Pathol. 2011 Mar; 135(3): 380-5. PMID: 21350091, PII: 135/3/380, DOI: 10.1309/AJCP00SHTQCVUYRI, ISSN: 1943-7722.

Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 426-9. PMID: 20581885, PII: bmt2010152, DOI: 10.1038/bmt.2010.152, ISSN: 1476-5365.

Engelhardt BG, Jagasia M, Savani BN, Bratcher NL, Greer JP, Jiang A, Kassim AA, Lu P, Schuening F, Yoder SM, Rock MT, Crowe JE. Regulatory T cell expression of CLA or a(4)ß(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant [print-electronic]. 2011 Mar; 46(3): 436-42. PMID: 20577222, PMCID: PMC3217583, PII: bmt2010127, DOI: 10.1038/bmt.2010.127, ISSN: 1476-5365.

Head DR, Jacobberger JW, Mosse C, Jagasia M, Dupont W, Goodman S, Flye L, Shinar A, McClintock-Treep S, Stelzer G, Briggs R, Shults K. Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis. Bone Marrow Res [print-electronic]. 2011; 2011: 950934. PMID: 22046573, PMCID: PMC3200066, DOI: 10.1155/2011/950934, ISSN: 2090-3006.

Griffith ML, Jagasia MH, Misfeldt AA, Chen H, Engelhardt BG, Kassim A, Savani BN, Survant M, Jagasia SM. Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2011 Jan; 17(1): 86-92. PMID: 20561594, PII: S1083-8791(10)00254-5, DOI: 10.1016/j.bbmt.2010.06.010, ISSN: 1523-6536.

Tedeschi SK, Jagasia M, Engelhardt BG, Domm J, Kassim AA, Chinratanalab W, Greenhut SL, Goodman S, Greer JP, Schuening F, Frangoul H, Savani BN. Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation. Cytotherapy [print-electronic]. 2011 Jan; 13(1): 78-82. PMID: 20586668, DOI: 10.3109/14653249.2010.495114, ISSN: 1477-2566.

Tedeschi SK, Savani BN, Jagasia M, Engelhardt B, Anasetti C, Barrett AJ, Lee S. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant [print-electronic]. 2010 Aug; 16(8): 1033-6. PMID: 20302962, PMCID: PMC3750708, PII: S1083-8791(10)00112-6, DOI: 10.1016/j.bbmt.2010.03.007, ISSN: 1523-6536.

Tatsas AD, Jagasia MH, Chen H, McCurley TL. Monitoring residual myeloma: high-resolution serum/urine electrophoresis or marrow biopsy with immunohistochemical analysis?. Am. J. Clin. Pathol. 2010 Jul; 134(1): 139-44. PMID: 20551278, PII: 134/1/139, DOI: 10.1309/AJCP69TCAVDGSCWI, ISSN: 1943-7722.

Griffith ML, Jagasia M, Jagasia SM. Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract. 2010 Jul; 16(4): 699-706. PMID: 20439241, PII: T44Q154K44003813, DOI: 10.4158/EP10027.RA, ISSN: 1934-2403.

Savani BN, Mielke S, Reddy N, Goodman S, Jagasia M, Rezvani K. Management of relapse after allo-SCT for AML and the role of second transplantation. Bone Marrow Transplant [print-electronic]. 2009 Dec; 44(12): 769-77. PMID: 19855439, PII: bmt2009300, DOI: 10.1038/bmt.2009.300, ISSN: 1476-5365.

Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol. Blood Marrow Transplant [print-electronic]. 2009 Oct; 15(10): 1288-95. PMID: 19747637, PMCID: PMC3159406, PII: S1083-8791(09)00289-4, DOI: 10.1016/j.bbmt.2009.06.007, ISSN: 1523-6536.

Washington K, Jagasia M. Pathology of graft-versus-host disease in the gastrointestinal tract. Hum. Pathol. 2009 Jul; 40(7): 909-17. PMID: 19524102, PII: S0046-8177(09)00118-X, DOI: 10.1016/j.humpath.2009.04.001, ISSN: 1532-8392.

Reddy N, Abel TW, Jagasia M, Morgan D, Weaver K, Greer J. Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab. Leuk. Lymphoma. 2009 Mar; 50(3): 460-2. PMID: 19266387, PII: 909254836, DOI: 10.1080/10428190802695827, ISSN: 1029-2403.

Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, Morgan D, Ruffner K, Schuening F. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol. Blood Marrow Transplant [print-electronic]. 2007 Oct; 13(10): 1207-15. PMID: 17889358, PII: S1083-8791(07)00338-2, DOI: 10.1016/j.bbmt.2007.07.001, ISSN: 1083-8791.

Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS. High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. Leuk. Lymphoma. 2007 Sep; 48(9): 1728-35. PMID: 17786708, PII: 781802102, DOI: 10.1080/10428190701534374, ISSN: 1042-8194.

Briggs RC, Shults KE, Flye LA, McClintock-Treep SA, Jagasia MH, Goodman SA, Boulos FI, Jacobberger JW, Stelzer GT, Head DR. Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis. Cancer Res. 2006 May 5/1/2006; 66(9): 4645-51. PMID: 16651415, PII: 66/9/4645, DOI: 10.1158/0008-5472.CAN-06-0229, ISSN: 0008-5472.

Welch DC, Wirth PS, Goldenring JR, Ness E, Jagasia M, Washington K. Gastric graft-versus-host disease revisited: does proton pump inhibitor therapy affect endoscopic gastric biopsy interpretation?. Am. J. Surg. Pathol. 2006 Apr; 30(4): 444-9. PMID: 16625089, PII: 00000478-200604000-00003, ISSN: 0147-5185.

Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant. 2005 Jun; 35(12): 1165-9. PMID: 15880129, PII: 1704994, DOI: 10.1038/sj.bmt.1704994, ISSN: 0268-3369.

Jagasia M, Morgan D, Goodman S, Hamilton K, Kinney M, Shyr Y, Stein R, Zic J, Greer J. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk. Lymphoma. 2004 Nov; 45(11): 2261-7. PMID: 15512815, PII: VDJ562CRM6ENDF6H, DOI: 10.1080/10428190412331272749, ISSN: 1042-8194.

Pereira Neto CC, Roman C, Johnson M, Jagasia M, Martin WH, Delbeke D. Positron emission tomography/computed tomography of a rare xanthogranulomatous process: Erdheim-Chester disease. Mol Imaging Biol. 2004 Jan; 6(1): 63-7. PMID: 15018830, PII: S1536163204000241, DOI: 10.1016/j.mibio.2004.01.023, ISSN: 1536-1632.

Johnson MD, Aulino JP, Jagasia M, Mawn LA. Erdheim-chester disease mimicking multiple meningiomas syndrome. AJNR Am J Neuroradiol. 2004 Jan; 25(1): 134-7. PMID: 14729543, ISSN: 0195-6108.

Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, Flexner JM, Cousar JB, Jagasia MH, McCurley TL, Greer JP. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk. Lymphoma. 2003 Feb; 44(2): 241-9. PMID: 12688340, DOI: 10.1080/1042819021000030054, ISSN: 1042-8194.

Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk. Lymphoma. 2001 Sep; 42(5): 913-22. PMID: 11697646, DOI: 10.3109/10428190109097710, ISSN: 1042-8194.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. Clin. Cancer Res. 2001 Jan; 7(1): 68-73. PMID: 11205920, ISSN: 1078-0432.

Stein RS, Wolff SN, Greer JP, Flexner JM, Goodman S, Jagasia M, Brandt SJ, Morgan DS, Arrowsmith E, McCurley TL. Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy. Leuk Lymp. 2001; ((42)): 913-22.

Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, CohenAG, Shyr Y, Carbone DP, DeVore RF. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A phase II multicenter study. Clinical Cancer Research. 2001; January.

Choy H, Chakravarthy A, Devore RF, Jagasia M, Hande KR, Roberts JR, Johnson DH, Yunus F. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC. Oncology (Williston Park, N.Y.). 2000 Jul; 14(7 Suppl 5): 43-6. PMID: 10981290, PII: 173444, ISSN: 0890-9091.

Choy H, Chakravarthy A, DeVore RF, Jagasia MH, Hande K, Roberts JR, Johnson DH. Weekly irinotecan and concurrent radiation therapy for stage III unresectable non-small cell lung cancer. Oncology. Suppl. 2000; ((5, July)).

DeVore RF, Jagasia M, Johnson DH. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. Semin. Oncol. 1997 Aug; 24(4 Suppl 12): S12-27. PMID: 9331116, ISSN: 0093-7754.

DeVore RF III, Jagasia MH, Johnson DH. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. Semin.Oncol. 1997; ((24)): S12-S12.

Jagasia MH, Cole FH, Stegman MH, Deaton P, Kennedy L. Video-assisted talc pleurodesis in the management of pleural effusion secondary to continuous ambulatory peritoneal dialysis: a report of three cases. Am.J.Kidney Dis. 1996; ((28)): 772-4.